Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06836557
PHASE3
Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis
Sponsor: Vanda Pharmaceuticals
View on ClinicalTrials.gov
Summary
This is a multicenter, open label, 3-month safety study with tradipitant in patients with idiopathic and diabetic gastroparesis.
Official title: A Multicenter, Open Label, 3-Month Safety Study with Tradipitant in Patients with Idiopathic or Diabetic Gastroparesis
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-01-09
Completion Date
2025-12
Last Updated
2025-02-20
Healthy Volunteers
No
Interventions
DRUG
Tradipitant
BID
Locations (3)
Vanda Investigational Site
Leuven, Belgium
Vanda Investigational Site
Liège, Belgium
Vanda Investigational Site
Leipzig, Germany